Coronavirus disease 2019 pneumonia in the newborn is a difficult-to-treat condition Early clinical signs of pneumonia are nonspecific and present as respiratory distress of varying severity, and tachypnea is a predominant clinical sign A 47-day-old, asymptomatic male newborn of coronavirus disease 2019 infected mother tested positive for coronavirus disease 2019 by reverse transcription polymerase chain reaction During hospitalization, he developed progressive tachypnea, tachycardia, and chest radiography abnormalities, and was diagnosed as coronavirus disease 2019 pneumonia He was treated with favipiravir, hydroxychloroquine, and lopinavir/ritonavir A favipiravir-based regimen may be the drug of choice for coronavirus disease 2019 pneumonia in the newborn
Favipiravir-based regimen for coronavirus disease 2019 pneumonia for a 47-day-old male newborn